However, long-term transcriptional mechanisms of G/GMCSF action are arguably of even greater importance in pathophysiological states involving chronic, continual release of G/GMCSF, such as tumor-affected tissues, rheumatoid arthritis, amongst others[14,15]. The gene discussed is CSF2; the disease is neoplasm.